Blood glucose testing, also known as blood glucose monitoring, is one of the main tools involved in controlling diabetes. Blood glucose testing is the process used to measure the concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter.
Due to the COVID-19 pandemic, the global Blood Glucose Testing Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Blood Glucose Testing Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Blood Glucose Testing Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The classification of Blood Glucose Testing includes Glucose Oxidase, Glucose Dehydrogenase and other, and the proportion of Glucose Oxidase in 2017 is about 50.6%.
This report focuses on Blood Glucose Testing Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Blood Glucose Testing Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Blood Glucose Testing Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Glucose Oxidase
Glucose Dehydrogenase
Other
Segment by Application
Hospitals
Clinics
Household
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
LIFESCAN
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
Nipro Dagnostics
77 Elektronika
AgaMatrix
Infopia
ALL Medicus
Terumo
SANNUO
Yicheng
Yuwell
Edan